Muhidin H Ibrahim,Atinc Tozsin,Yuhong Yuan et al.
Muhidin H Ibrahim et al.
Background: Urolithiasis is climate-sensitive and increasingly prevalent, but the environmental impact of its care remains poorly defined. The aim of the study is to map existing evidence on the environmental footprint of...
Giampaolo Bianchi,Natali Rodriguez Peñaranda,Stefano Puliatti
Giampaolo Bianchi
Is orthotopic neobladder truly a urinary diversion? Revisiting post-cystectomy terminology [0.03%]
原位新膀胱术真的是尿流改道术吗？再谈根治性 cystectomy 术后术语问题
Francesco Esperto,Rocco Papalia,Arianna Pischetola et al.
Francesco Esperto et al.
YAU-RCC spotlight: where evidence ends and consensus begins for renal cell carcinoma. Insights from the Advanced Urologic Cancer Consensus Conference (AUC3) 2025 [0.03%]
肾细胞癌的证据终结与共识开始：高级泌尿系统癌症共识会议（AUC3 2025）的启示
Veronica Mollica,Emre Yekedüz,Daniele Amparore et al.
Veronica Mollica et al.
YAU-RCC Insights from UROonco25 and EMUC25: renal cell carcinoma in a multidisciplinary era [0.03%]
耶鲁-肾细胞癌多学科时代下的泌尿肿瘤和EMUC会议见解renal cell carcinoma
Savio D Pandolfo,Riccardo Campi,Daniele Amparore;European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group
Savio D Pandolfo
Sara Riolo,Antonio Celia
Sara Riolo
YAU-RCC Insights from ASCO GU 2026: emerging advances in renal cell carcinoma management [0.03%]
2026年ASCO-GU大会肾细胞癌管理的最新进展：YAU-RCC见解
Giulio Francolini,Veronica Mollica,Ronan Flippot et al.
Giulio Francolini et al.
PSMA expression: enhancing prostate cancer diagnosis at the biopsy stage [0.03%]
PSMA表达：在活检阶段增强前列腺癌的诊断
Rosario Leonardi,Massimiliano Mazza,Fabio Nicolini et al.
Rosario Leonardi et al.
From the 10-20 mm gray zone to a 15 mm stone size cutoff for pediatric urolithiasis management: do guidelines need revisiting? . A systematic review and meta-analysis by the EAU Section of Endourology [0.03%]
从儿童尿路结石管理的10-20mm灰区到15mm大小截点：指南需要重新审视吗？一项系统评价和meta分析（由EAU碎石术分会发表）
Selcuk Guven,Mehmet G Sonmez,Atinc Tozsin et al.
Selcuk Guven et al.
Background: Pediatric urolithiasis guidelines recommend ESWL, RIRS, or PCNL for stones within the 10-20 mm range but this broad interval often complicates treatment selection. This systematic review aimed to define a clea...
The old standard still holds up: reading CREST, POTOMAC, and ALBAN in BCG-naive high-risk non-muscle-invasive bladder cancer [0.03%]
老标准依然适用：BCG无反应高危非肌层浸润性膀胱癌中CREST、POTOMAC及ALBAN的作用
Andrea Mari,Luca Lambertini,Simone Albisinni et al.
Andrea Mari et al.